NOS3 and pancreatic neoplasm: However, genetic ablation of NOS3 or endothelial NOS inhibited the development of precursor lesions or pancreatic intraepithelial neoplasia (PanINs) in a genetically engineered mouse model of pancreatic cancer [9].